SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 3, 2008
GRAYMARK HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
| | | | |
Oklahoma | | 000-50638 | | 20-0180812 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
101 N. Robinson, Suite 920 | | |
Oklahoma City, Oklahoma 73102 | | 73102 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code:(405) 601-5300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | |
o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
o | | Pre-commencement communications pursuant to Rule 14a-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | |
Item 7.01 | | Regulation FD Disclosure. |
On June 3, 2008, we, at Graymark Healthcare, Inc. issued a press release announcing completion of the acquisition by ApothecaryRx, LLC, our wholly-owned subsidiary, of four pharmacies in the Greater Chicago Area.
| | |
Item 9.01 | | Financial Statements and Exhibits. |
(d) Exhibits.
| | | | |
| | | | |
| 99.1 | | | Press Release issued June 3, 2008. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| GRAYMARK HEALTHCARE, INC. (Registrant) | |
| By: | /S/STANTON NELSON | |
| | Stanton Nelson, Chief Executive Officer | |
| | | |
|
Date: June 5, 2008
-2-